Vascular Repair After Menstruation Involves Regulation of Vascular Endothelial Growth Factor-Receptor Phosphorylation by sFLT-1

This publication has 52 references indexed in Scilit:

• No Cyclicity in Serum Vascular Endothelial Growth Factor During Normal Menstrual Cycle but Significant Luteal Phase Elevation During an In Vitro Fertilization Program
  American Journal of Reproductive Immunology, 2000
• Endometrial Endothelial Cells Express Estrogen and Progesterone Receptors and Exhibit a Tissue Specific Response to Angiogenic Growth Factors
  Microcirculation, 1999
• Endometrial microvascular growth in normal and dysfunctional states
  Human Reproduction Update, 1998
• Identification of a Natural Soluble Form of the Vascular Endothelial Growth Factor Receptor, FLT-1, and Its Heterodimerization with KDR
  Biochemical and Biophysical Research Communications, 1996
• Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium.
  Journal of Clinical Investigation, 1996
• Keratinocyte-Derived Vascular Permeability Factor (Vascular Endothelial Growth Factor) Is a Potent Mitogen for Dermal Microvascular Endothelial Cells
  Journal of Investigative Dermatology, 1995
• Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis.
  The Journal of Experimental Medicine, 1994
• Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.
  Proceedings of the National Academy of Sciences, 1993
• Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
  Nature, 1992
• Endometrial Microstructure: Structure-Function Relationships Throughout the Menstrual Cycle
  Seminars in Reproductive Medicine, 1983